OPKO Health buys blood-testing company

OPKO Health, the Miami healthcare company, announced Friday it has purchased Prost-Data, which operates the Nashville-based OURLab, a company with 18 blood-testing sites through the United States and a sales force that deals mainly with urologists..

OPKO said the deal provides it with a commercial platform to launch sales of its 4Kscore, which offers a new approach to testing for prostate cancer.

In a press release, the company said 4Kscore “may reduce the number of unnecessary prostate biopsies by 50 percent or more.”

In a filing with the Security and Exchange Commission, OPKO said that Prost-Data has one shareholder, Jonathan Oppenheimer, a physician. OPKO will pay Oppenheimer’s company $9.4 million plus $30.6 million in OPKO shares.

Read more Healthcare Reform stories from the Miami Herald

Miami Herald

Join the

The Miami Herald is pleased to provide this opportunity to share information, experiences and observations about what's in the news. Some of the comments may be reprinted elsewhere on the site or in the newspaper. We encourage lively, open debate on the issues of the day, and ask that you refrain from profanity, hate speech, personal comments and remarks that are off point. Thank you for taking the time to offer your thoughts.

The Miami Herald uses Facebook's commenting system. You need to log in with a Facebook account in order to comment. If you have questions about commenting with your Facebook account, click here.

Have a news tip? You can send it anonymously. Click here to send us your tip - or - consider joining the Public Insight Network and become a source for The Miami Herald and el Nuevo Herald.

Hide Comments

This affects comments on all stories.

Cancel OK

  • Marketplace

Today's Circulars

  • Quick Job Search

Enter Keyword(s) Enter City Select a State Select a Category